| Name |
Dalacin C 300 mg tvrde kapsule |
| Marketing Authorisation Number |
HR-H-200113413 |
| Active Substance |
klindamicinklorid |
| Composition |
1 tvrda kapsula sadrži 300 mg klindamicina u obliku klindamicinklorida |
| Pharmaceutical Form |
kapsula, tvrda |
| Manufacturer |
Fareva Amboise, Poce-sur-Cisse, Francuska |
| Marketing Authorisation Holder |
Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date |
20.05.2020 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/18-02/73 |
| Registration Number |
381-12-01/38-20-06 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
neponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
J01FF01 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
